Cargando…

Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker

We present a unique case of a massive calcium channel antagonist overdose in a patient with a permanent pacemaker. Upon presentation after the acute overdose, the patient’s cardiac device was found to be pacing to an adequate rate (75 beats per minute) and she was admitted to the cardiac intensive c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibbons, Patric W., Chai, Peter R., Erickson, Timothy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103801/
https://www.ncbi.nlm.nih.gov/pubmed/37063371
_version_ 1785025926488129536
author Gibbons, Patric W.
Chai, Peter R.
Erickson, Timothy B.
author_facet Gibbons, Patric W.
Chai, Peter R.
Erickson, Timothy B.
author_sort Gibbons, Patric W.
collection PubMed
description We present a unique case of a massive calcium channel antagonist overdose in a patient with a permanent pacemaker. Upon presentation after the acute overdose, the patient’s cardiac device was found to be pacing to an adequate rate (75 beats per minute) and she was admitted to the cardiac intensive care unit. Approximately 24 hours after her ingestion, she acutely decompensated and became hypotensive. The patient was started on infusions of norepinephrine, epinephrine, phenylephrine, and vasopressin. Her mean arterial pressure was unresponsive to multi-vasopressor therapy. She was then given a bolus of methylene blue and high-dose insulin euglycemic therapy. Despite these treatments, the patient remained hypotensive Therefore, intralipid emulsion therapy and IV epinephrine pushes were also administered. As a result of her shock and hemodynamic instability, her course was further complicated by hypoxemic respiratory failure for which she required ventilatory support and developed oliguric renal failure for which she was initiated on continuous veno-venous hemofiltration. This case emphasizes the challenges in managing complex physiology associated with nodal agent toxicity and is the first, to our knowledge, to describe management in a patient who already had a pacemaker, though it was ultimately ineffective in avoiding the patient’s profound decompensation.
format Online
Article
Text
id pubmed-10103801
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-101038012023-04-14 Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker Gibbons, Patric W. Chai, Peter R. Erickson, Timothy B. J Cardiol Case Reports Article We present a unique case of a massive calcium channel antagonist overdose in a patient with a permanent pacemaker. Upon presentation after the acute overdose, the patient’s cardiac device was found to be pacing to an adequate rate (75 beats per minute) and she was admitted to the cardiac intensive care unit. Approximately 24 hours after her ingestion, she acutely decompensated and became hypotensive. The patient was started on infusions of norepinephrine, epinephrine, phenylephrine, and vasopressin. Her mean arterial pressure was unresponsive to multi-vasopressor therapy. She was then given a bolus of methylene blue and high-dose insulin euglycemic therapy. Despite these treatments, the patient remained hypotensive Therefore, intralipid emulsion therapy and IV epinephrine pushes were also administered. As a result of her shock and hemodynamic instability, her course was further complicated by hypoxemic respiratory failure for which she required ventilatory support and developed oliguric renal failure for which she was initiated on continuous veno-venous hemofiltration. This case emphasizes the challenges in managing complex physiology associated with nodal agent toxicity and is the first, to our knowledge, to describe management in a patient who already had a pacemaker, though it was ultimately ineffective in avoiding the patient’s profound decompensation. 2022 2022-01-27 /pmc/articles/PMC10103801/ /pubmed/37063371 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Article
Gibbons, Patric W.
Chai, Peter R.
Erickson, Timothy B.
Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker
title Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker
title_full Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker
title_fullStr Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker
title_full_unstemmed Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker
title_short Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker
title_sort complex management of av nodal agent toxicity in patients with cardiac devices: massive calcium channel antagonist overdose in a patient with a permanent pacemaker
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103801/
https://www.ncbi.nlm.nih.gov/pubmed/37063371
work_keys_str_mv AT gibbonspatricw complexmanagementofavnodalagenttoxicityinpatientswithcardiacdevicesmassivecalciumchannelantagonistoverdoseinapatientwithapermanentpacemaker
AT chaipeterr complexmanagementofavnodalagenttoxicityinpatientswithcardiacdevicesmassivecalciumchannelantagonistoverdoseinapatientwithapermanentpacemaker
AT ericksontimothyb complexmanagementofavnodalagenttoxicityinpatientswithcardiacdevicesmassivecalciumchannelantagonistoverdoseinapatientwithapermanentpacemaker